Search

Home > Lung Cancer Considered > FDA Approval: Zongertinib for HER2 Mutant NSCLC
Podcast: Lung Cancer Considered
Episode:

FDA Approval: Zongertinib for HER2 Mutant NSCLC
Category: Science & Medicine
Duration: 00:41:55
Publish Date: 2025-08-12 13:00:23
Description: FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC
Total Play: 0